---
audienceLevel: patient
cancerTypes:
- lung
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Binimetinib - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/binimetinib
version: v1
---

# Binimetinib - NCI

# Binimetinib

Placeholder slot

(BIH-nee-MEH-tih-nib)

This page contains brief information about binimetinib
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Mektovi

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c3408ac-d401-4925-8a03-26591afbc240&audience=consumer)

## Use in Cancer

Binimetinib
is approved to be used with [encorafenib](/Common/PopUps/popDefinition.aspx?id=793869&version=Patient&language=English) to treat patients whose cancer has a certain [mutation](/Common/PopUps/popDefinition.aspx?id=46063&version=Patient&language=English) in the *[BRAF](/Common/PopUps/popDefinition.aspx?id=561325&version=Patient&language=English)* gene, including:

- **[Melanoma](/Common/PopUps/popDefinition.aspx?id=45135&version=Patient&language=English)** that cannot be removed by surgery or has spread to other parts of the body.
- **[Non-small cell lung cancer](/Common/PopUps/popDefinition.aspx?id=45323&version=Patient&language=English).** It is in adults whose cancer has spread to other parts of the body.

Binimetinib
is also being studied in the treatment of other types of
cancer.

## More About Binimetinib

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653635) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Binimetinib](https://medlineplus.gov/druginfo/meds/a618041.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Androgen Receptor May Explain Sex Differences in Melanoma Treatment Response](https://www.cancer.gov/news-events/cancer-currents-blog/2022/melanoma-treatment-androgen-receptor)

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Binimetinib](https://www.cancer.gov/research/participate/clinical-trials/intervention/C84865) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
